KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbbVie (ABBV) Non-Current Assets (2016 - 2025)

AbbVie (ABBV) has disclosed Non-Current Assets for 14 consecutive years, with $104.9 billion as the latest value for Q4 2025.

  • On a quarterly basis, Non-Current Assets fell 4.27% to $104.9 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $426.7 billion, a 3.76% decrease, with the full-year FY2025 number at $104.9 billion, down 4.27% from a year prior.
  • Non-Current Assets was $104.9 billion for Q4 2025 at AbbVie, roughly flat from $105.4 billion in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $123.9 billion in Q1 2021 to a low of $101.7 billion in Q4 2023.
  • A 5-year average of $111.3 billion and a median of $109.8 billion in 2024 define the central range for Non-Current Assets.
  • Peak YoY movement for Non-Current Assets: surged 214.22% in 2021, then decreased 8.89% in 2025.
  • AbbVie's Non-Current Assets stood at $118.6 billion in 2021, then decreased by 6.96% to $110.3 billion in 2022, then fell by 7.82% to $101.7 billion in 2023, then rose by 7.74% to $109.6 billion in 2024, then fell by 4.27% to $104.9 billion in 2025.
  • Per Business Quant, the three most recent readings for ABBV's Non-Current Assets are $104.9 billion (Q4 2025), $105.4 billion (Q3 2025), and $107.9 billion (Q2 2025).